Diagnosis of Clostridium difficile infection treat the patient, not the test

JAMA Internal Medicine

Volumn 175, Issue 11, 2015, Pages 1801-1802

  Dubberke, Erik R ^a   Burnham, Carey Ann D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN;

BACTERIUM DETECTION; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FECES ANALYSIS; HUMAN; NOTE; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; CLOSTRIDIUM INFECTION; CROSS INFECTION; FEMALE; HEALTH SERVICE; ISOLATION AND PURIFICATION; MALE; UTILIZATION;

BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FEMALE; HUMANS; MALE; MEDICAL OVERUSE; POLYMERASE CHAIN REACTION;

EID: 84946124203     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.4607     Document Type: Note

References (7)

1. Cohen SH, Gerding DN, Johnson S, et al; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-455.
2. Polage CR, Gyorke CE, Kennedy MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era [published online September 8, 2015]. JAMA Intern Med. doi:10.1001/jamainternmed.2015.4114.
3. Planche TD, Davies KA, Coen PG, et al. Differences in outcome according to Clostridium difficile testingmethod: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis. 2013;13(11):936-945.
4. Dubberke ER, Han Z, Bobo L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol. 2011;49(8):2887-2893.
5. Gould CV, Edwards JR, Cohen J, et al; Clostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis. 2013;57(9):1304-1307.
6. Johnson S, Homann SR, Bettin KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled trial. Ann Intern Med. 1992;117(4):297-302.
7. Buckel WR, Avdic E, Carroll KC, Gunaseelan V, Hadhazy E, Cosgrove SE. Gut check: Clostridium difficile testing and treatment in the molecular testing era. Infect Control Hosp Epidemiol. 2015;36 (2):217-221.